TY - JOUR T1 - Predictors of Incident Viral Symptoms Ascertained in the Era of Covid-19 JF - medRxiv DO - 10.1101/2020.09.24.20197632 SP - 2020.09.24.20197632 AU - Gregory M Marcus AU - Jeffrey E Olgin AU - Noah D Peyser AU - Eric Vittinghoff AU - Vivian Yang AU - Sean Joyce AU - Robert Avram AU - Geoffrey H Tison AU - David Wen AU - Xochitl Butcher AU - Helena Eitel AU - Mark J Pletcher Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/25/2020.09.24.20197632.abstract N2 - Background In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection, particularly readily modifiable exposures and behaviors, is required to identify effective strategies against viral infection and transmission.Methods We conducted a world-wide mobile application-based prospective cohort study available to English speaking adults with a smartphone. We collected self-reported characteristics, exposures, and behaviors, as well as smartphone-based geolocation data. Our main outcome was incident symptoms of viral infection, defined as fevers and chills plus one other symptom previously shown to occur with SARS-CoV-2 infection, determined by daily surveys.Findings Among 14, 335 participants residing in all 50 US states and 93 different countries followed for a median 21 days (IQR 10-26 days), 424 (3%) developed incident viral symptoms. In pooled multivariable logistic regression models, female biological sex (odds ration [OR] 1.75, 95% CI 1.39-2.20, p<0.001), anemia (OR 1.45, 95% CI 1.16-1.81, p=0.001), hypertension (OR 1.35, 95% CI 1.08-1.68, p=0.007), cigarette smoking in the last 30 days (OR 1.86, 95% CI 1.35-2.55, p<0.001), any viral symptoms among household members 6-12 days prior (OR 2.06, 95% CI 1.67-2.55, p<0.001), and the maximum number of individuals the participant interacted with within 6 feet in the past 6-12 days (OR 1.15, 95% CI 1.06-1.25, p<0.001) were each associated with a higher risk of developing viral symptoms. Conversely, a higher subjective social status (OR 0.87, 95% CI 0.83-0.93, p<0.001), at least weekly exercise (OR 0.57, 95% CI 0.47-0.70, p<0.001), and sanitizing one’s phone (OR 0.79, 95% CI 0.63-0.99, p=0.037) were each associated with a lower risk of developing viral symptoms.Interpretation While several immutable characteristics were associated with the risk of developing viral symptoms, multiple immediately modifiable exposures and habits that influence risk were also observed, potentially identifying readily accessible strategies to mitigate risk in the Covid-19 era.Funding This study was funded by IU2CEB021881-01 and 3U2CEB021881-05S1 from the NIH/ NIBIB to Drs. Marcus, Olgin, and Pletcher.Evidence before this study Predictors of incident viral infection have been determined largely from cross-sectional studies prone to recall bias among individuals representing geographically constrained regions, and most were conducted before the era of the current Covid-19 pandemic.Added value of this study We conducted a world-wide, mobile application-based, longitudinal cohort study utilizing time-updated predictors and outcomes, providing novel and current information regarding risk-factors for incident viral symptoms based on real-time information in the era of Covid-19.Implications of all the available evidence These data suggest that certain immutable characteristics influence the risk for incident viral symptoms, while smoking cessation, physical distancing to avoid contact with individuals outside the household, regular exercise, and sanitizing one’s phone may each help mitigate the risk of viral infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by IU2CEB021881-01 and 3U2CEB021881-05S1 from the NIH/ NIBIB to Drs. Marcus, Olgin, and Pletcher.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UCSF IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesInterested investigators can submit a proposal to the Eureka Digital Research Platform Executive Committee at UCSF ER -